Owens & Minor (NYSE:OMI) Stock Rating Lowered by StockNews.com

Owens & Minor (NYSE:OMIGet Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.

Several other research analysts also recently commented on OMI. TheStreet upgraded Owens & Minor from a “d+” rating to a “c-” rating in a report on Monday, March 4th. UBS Group lowered their price objective on Owens & Minor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, January 29th. SVB Leerink initiated coverage on shares of Owens & Minor in a research note on Monday, February 26th. They issued a “market perform” rating and a $24.00 target price for the company. Leerink Partnrs restated a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. Finally, Robert W. Baird lowered their price objective on shares of Owens & Minor from $28.00 to $24.00 and set a “neutral” rating for the company in a research note on Monday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Owens & Minor has an average rating of “Hold” and a consensus target price of $23.29.

Read Our Latest Analysis on OMI

Owens & Minor Trading Down 1.6 %

NYSE OMI traded down $0.31 on Tuesday, hitting $18.91. 1,151,930 shares of the stock were exchanged, compared to its average volume of 681,495. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.56 and a current ratio of 1.16. Owens & Minor has a 52-week low of $13.64 and a 52-week high of $28.35. The firm has a market capitalization of $1.45 billion, a P/E ratio of -37.08, a P/E/G ratio of 0.57 and a beta of 0.52. The stock has a fifty day moving average price of $25.14 and a two-hundred day moving average price of $21.56.

Owens & Minor (NYSE:OMIGet Free Report) last released its quarterly earnings results on Friday, May 3rd. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. Owens & Minor had a negative net margin of 0.37% and a positive return on equity of 12.97%. The firm had revenue of $2.61 billion during the quarter, compared to analysts’ expectations of $2.61 billion. During the same period in the previous year, the company earned $0.05 EPS. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. Research analysts forecast that Owens & Minor will post 1.54 EPS for the current fiscal year.

Insider Transactions at Owens & Minor

In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at $1,791,350. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, SVP Jonathan A. Leon sold 5,000 shares of the stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the sale, the senior vice president now directly owns 84,673 shares of the company’s stock, valued at $2,103,277.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Michael Wayne Lowry sold 10,000 shares of Owens & Minor stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the completion of the transaction, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The disclosure for this sale can be found here. Company insiders own 2.62% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

Institutional investors have recently modified their holdings of the business. Riverview Trust Co acquired a new stake in Owens & Minor in the first quarter valued at approximately $25,000. Hexagon Capital Partners LLC grew its stake in Owens & Minor by 1,240.2% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after acquiring an additional 1,451 shares during the period. GAMMA Investing LLC increased its holdings in Owens & Minor by 52.1% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock worth $46,000 after acquiring an additional 563 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in shares of Owens & Minor during the 3rd quarter worth about $29,000. Finally, Quest Partners LLC acquired a new position in shares of Owens & Minor during the fourth quarter valued at approximately $41,000. 98.04% of the stock is currently owned by institutional investors and hedge funds.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Stories

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.